Skip to main content
Premium Trial:

Request an Annual Quote

SomaLogic Raises $16.5M

NEW YORK (GenomeWeb) – In a notice filed on Friday with the US Securities and Exchange Commission, SomaLogic disclosed that it has raised $16.5 million.

According to the SEC document, the sale took place on Oct. 17 with equity going to two unidentified investors.

Last month, Novartis agreed to take an equity stake in SomaLogic as part of an extension of a multi-year agreement between the two companies. It is unclear if the recent financing relates to that agreement. SomaLogic declined to comment on the offering or identify the investors.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.